Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2019

Feb 20, 2019

29777_dirs_2019-02-20_5fc73b94-ab25-4bf6-a337-f335a70f99c4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2019-02-16

Reporting Person: Karam Sammy (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-16 Common shares without par value F 814 $75.25 Disposed 17853 Direct
2019-02-17 Common shares without par value F 771 $75.25 Disposed 17082 Direct
2019-02-19 Common shares without par value F 792 $75.25 Disposed 16290 Direct

Footnotes

F1: Includes shares acquired under the Abbott Laboratories 2017 Employee Stock Purchase Plan for Non-U.S. Employees.